We are international
publications TEXT SIZE   
the understanding series    back

ASH 2011: Dr. Lentzsch - Combination of Bendamustine, Lenalidomide, and Dexamethasone (BLD) in Patients with Refractory or Relapsed Multiple Myeloma Is Safe and Highly Effective: Results of Phase I/II Open-Label, Dose Escalation Study
Suzanne Lentzsch, MD, PhD
University of Pittsburgh School of Medicine and Cancer Institute
Pittsburgh, Pennsylvania, USA

To view the video full screen, click on the small button next to the volume control in the lower right hand corner.

 related articles